Virtual Medicinal Product (VMP) - Co-amilofruse 1.25mg/10mg/5ml oral suspension
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Co-amilofruse 1.25mg/10mg/5ml oral suspension | Start Date 15-08-2007 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Name Basis
- BAN - British Approved Name
Codes
- ATC Code
- C03EB01
- BNF Codes
-
- BNF code 02020400
| Code | Start Date | End Date |
|---|---|---|
| 11814411000001102 | 15-08-2007 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Amiloride hydrochloride | Based on Ingredient Substance | 250 microgram | 1 ml | |
| Furosemide | Based on Ingredient Substance | 2 mg | 1 ml |
Name
Amiloride hydrochloride
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
250
Strength and UOM (Dmr)
1
Name
Furosemide
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
2
Strength and UOM (Dmr)
1
Parent Products
-
VTMCo-amilofruse
-
VMP(Current) Co-amilofruse 1.25mg/10mg/5ml oral s...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 ml |